A detailed history of Forsta Ap Fonden transactions in Exact Sciences Corp stock. As of the latest transaction made, Forsta Ap Fonden holds 38,800 shares of EXAS stock, worth $2.39 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,800
Holding current value
$2.39 Million
% of portfolio
0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$42.43 - $70.83 $1.65 Million - $2.75 Million
38,800 New
38,800 $2.64 Million
Q1 2024

May 07, 2024

BUY
$56.27 - $73.77 $225,080 - $295,080
4,000 Added 11.7%
38,200 $2.64 Million
Q4 2023

Feb 06, 2024

SELL
$59.06 - $75.72 $1.36 Million - $1.74 Million
-23,000 Reduced 40.21%
34,200 $2.53 Million
Q2 2023

Aug 03, 2023

BUY
$62.68 - $95.05 $3.59 Million - $5.44 Million
57,200 New
57,200 $5.37 Million
Q4 2022

Feb 02, 2023

SELL
$30.35 - $53.15 $661,630 - $1.16 Million
-21,800 Reduced 31.32%
47,800 $2.37 Million
Q3 2022

Oct 17, 2022

BUY
$31.97 - $49.37 $1.52 Million - $2.35 Million
47,700 Added 217.81%
69,600 $2.26 Million
Q2 2022

Aug 11, 2022

SELL
$35.61 - $76.23 $263,514 - $564,102
-7,400 Reduced 25.26%
21,900 $863,000
Q1 2022

May 09, 2022

SELL
$57.56 - $82.54 $546,820 - $784,130
-9,500 Reduced 24.48%
29,300 $2.05 Million
Q4 2021

Feb 11, 2022

BUY
$72.5 - $100.68 $2.18 Million - $3.02 Million
30,000 Added 340.91%
38,800 $3.02 Million
Q3 2021

Nov 10, 2021

SELL
$90.24 - $124.05 $252,672 - $347,340
-2,800 Reduced 24.14%
8,800 $840,000
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $1.76 Million - $2.62 Million
-18,800 Reduced 61.84%
11,600 $1.44 Million
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $233,140 - $310,020
2,000 Added 7.04%
30,400 $4.01 Million
Q4 2020

Feb 09, 2021

BUY
$99.61 - $142.12 $488,089 - $696,388
4,900 Added 20.85%
28,400 $3.76 Million
Q3 2020

Oct 22, 2020

BUY
$72.92 - $102.01 $328,140 - $459,045
4,500 Added 23.68%
23,500 $2.4 Million
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $1.06 Million - $1.76 Million
19,000 New
19,000 $1.65 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.